Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 Study

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 3, 2017

Conditions
Adiposity
Interventions
DRUG

Anakinra

Subjects will receive Anakinra infusion and afterwards they will be fed a very fat containing meal, and postprandial fatigue will be measured regularly until 3,5 hour after the meal.

DRUG

NaCl

subjects will receive NaCl infusion and afterwards they will be fed a very fat containing meal, and postprandial fatigue will be measured regularly until 3,5 hour after the meal.

Trial Locations (1)

CH-4031 Basel

University Hospital Basel, Department of Endocrinology, Diabetes and Metabolism, Basel

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02916355 - Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 Study | Biotech Hunter | Biotech Hunter